GMP Documentation, Identity Testing Continue To Trip Supplement Firms
This article was originally published in The Tan Sheet & The Rose Sheet
Executive Summary
Warnings from FDA's Office of Regulatory Affairs make clear that failing to document compliance with each GMP requirement renders those parts of the process noncompliant. Warning letters posted March 22 also include FDA's latest enforcement against firms marketing bulk caffeine.
You may also be interested in...
US DoJ Has Own Eyes On Consumer Health Fraud
Firms moving from noncompliance to compliance with FDA or FTC requirements still could hear from federal prosecutors. “Our office has grown to the point that we generate a fair amount of work ourselves,” says Patrick Runkle, a trial attorney in DoJ Consumer Protection Branch.
Own-Labeler Lesson, Ingredient-Testing Lapse Noted Again In FDA Warnings
Sportron International "cannot contract out its ultimate responsibility to ensure that the dietary supplement it places into commerce" is compliant, and Absonutrix failed "to conduct at least one appropriate test or examination to verify the identity of a dietary ingredient," say FDA warning letters listing some of the most frequently noted problems found in GMP and labeling inspections.
FDA Takes The Measure Of Bulk Caffeine In Warnings About Labels
Serving amounts such as one-sixteenth of a teaspoon indicated on product labels “cannot be accurately measured using common household measuring tools,” FDA says. NPA, however, suggests the agency gives too little credit to consumers’ measuring skills.